期刊
LEUKEMIA & LYMPHOMA
卷 53, 期 9, 页码 1769-1778出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2012.663085
关键词
HDACis; WNT/beta-catenin signaling; T-ALL; apoptosis; cell cycle
资金
- National Natural Science Foundation of China [30871088, 81070407, 81000223]
- Eleventh Five-Year National Science and Technology Support Program of China
- SRFDP of the Educational Ministry [20100131110060]
- Shandong Technological Development Project [2009GG20002020, 2008GJHZ10202, 2008BS03001, 2009HD012, BS2009SW014, 2007BS03049, 2010GSF10235]
- Independent Innovation Fund of Shandong University, IIFSDU [yzc10071]
Histone deacetylase inhibitors (HDACis) are promising agents for the treatment of acute T lymphoblastic leukemia (T-ALL). However, the underlying mechanisms remain to be elucidated. Based on a recent study showing that HDACis were able to modulate WNT/beta-catenin signaling, we further investigated the influence of HDACis on WNT/beta-catenin signaling in T-ALL cells and modulation of WNT/beta-catenin signaling in mediating anti-leukemic effects of HDACis. Results from Western blotting, immunocytochemistry and a luciferase reporter assay consistently suggested that two HDACis, valproic acid (VPA) and suberoyl bishydroxamic acid (SBHA), augmented WNT/beta-catenin signaling in T-ALL cells. Meanwhile, VPA and SBHA dramatically inhibited cell growth, blocked G2/M cell cycle progression and increased p21(WAF1) expression. In addition, the levels of cleaved caspase-9, caspase-3 and poly(ADP-ribose) polymerase (PARP) were elevated, indicating induction of apoptosis. Furthermore, flow cytometry and Western blot for cleaved PARP showed that targeting beta-catenin with shRNA attenuated the apoptosis induced by VPA and SBHA. These data demonstrate that HDACis exert profound anti-leukemic effects partly by augmentation of WNT/beta-catenin signaling. Using HDACis to modulate WNT/beta-catenin signaling could be an attractive new strategy for the treatment of T-ALL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据